2025 annual financial data
Seres Therapeutics 2025 Financial results
Direct answer
Revenue was 789,000 USD.
Operating income was -93.97M USD and net income was 5.7M USD.
Operating cash flow was 1.12M USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 789,000 USD
- Operating income
- -93.97M USD
- Net income
- 5.7M USD
- Operating cash flow
- 1.12M USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Seres Therapeutics financial years